Full text is available at the source.
Abstract
The expression of mA demethylases FTO and ALKBH5 is significantly lower in hepatocellular carcinoma (HCC) than in non-cancerous tissues (both p<0.001).
- Global mA quantification showed no significant difference between HCC and non-cancerous liver tissue.
- Lower expression levels of the mA demethylases FTO and ALKBH5 in HCC could suggest their role in cancer development.
- In non-cancerous tissues, low ALKBH5 expression is associated with worse recurrence-free survival (median of 16.3 vs. 38.9 months, p=0.001).
- These findings may indicate that mA and its demethylases in surrounding non-cancerous tissues are involved in HCC malignancy after surgical resection.
Simplified